A fundamental control performance limit for a class of positive nonlinear systems
暂无分享,去创建一个
Graham C. Goodwin | María M. Seron | Diego S. Carrasco | Adrian M. Medioli | G. Goodwin | M. Seron | D. Carrasco
[1] K. Kumareswaran. Closed-loop insulin delivery in adults with type 1 diabetes , 2012 .
[2] Keith Godfrey,et al. Compartmental Models and Their Application , 1983 .
[3] Nejat Olgac,et al. Investigation of Local Stability Transitions in the Spectral Delay Space and Delay Space , 2014 .
[4] R. Bergman. Minimal Model: Perspective from 2005 , 2006, Hormone Research in Paediatrics.
[5] L. Magni,et al. Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.
[6] Patrick McElduff,et al. Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy , 2014, BMJ Open Diabetes Research and Care.
[7] B. Bequette. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.
[8] Graham C. Goodwin,et al. Fundamental Limitations in Filtering and Control , 1997 .
[9] C. Cobelli,et al. The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes , 2016, Diabetes Care.
[10] E. Atlas,et al. MD-Logic Artificial Pancreas System , 2010, Diabetes Care.
[11] Nejat Olgaç,et al. Stability analysis for LTI systems with multiple time delays using the bounds of its imaginary spectra , 2017, Syst. Control. Lett..
[12] Nejat Olgaç,et al. Combination of sign inverting and delay scheduling control concepts for multiple-delay dynamics , 2015, Syst. Control. Lett..
[13] E. Coddington. An Introduction to Ordinary Differential Equations , 1961 .
[14] Lauren M. Huyett,et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms , 2014, Diabetes Care.
[15] Patrick McElduff,et al. Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive , 2013, Diabetes Care.
[16] S. Aronoff,et al. Glucose Metabolism and Regulation: Beyond Insulin and Glucagon , 2004 .
[17] S. Rinaldi,et al. Positive Linear Systems: Theory and Applications , 2000 .
[18] Maria M. Seron,et al. Optimality of Unconstrained Pulse Inputs to the Bergman Minimal Model , 2018, IEEE Control Systems Letters.
[19] A. Berman,et al. Nonnegative matrices in dynamic systems , 1979 .
[20] C. Kenny. When hypoglycemia is not obvious: diagnosing and treating under-recognized and undisclosed hypoglycemia. , 2014, Primary care diabetes.
[21] F. Doyle,et al. Quest for the Artificial Pancreas: Combining Technology with Treatment , 2010, IEEE Engineering in Medicine and Biology Magazine.
[22] I. Horowitz. Synthesis of feedback systems , 1963 .
[23] M. A. Krasnoselʹskii,et al. Positive Linear Systems, the Method of Positive Operators , 1989 .
[24] Graham C. Goodwin,et al. Control System Design , 2000 .
[25] R. Hovorka,et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.
[26] Patricio Colmegna,et al. Analysis of three T1DM simulation models for evaluating robust closed-loop controllers , 2014, Comput. Methods Programs Biomed..
[27] Nejat Olgaç,et al. Critical Effects of the Polarity Change in Delayed States Within an LTI Dynamics With Multiple Delays , 2015, IEEE Transactions on Automatic Control.
[28] R. Goody,et al. The original Michaelis constant: translation of the 1913 Michaelis-Menten paper. , 2011, Biochemistry.
[29] M. Atkinson,et al. Type 1 diabetes , 2014, The Lancet.
[30] Eyal Dassau,et al. Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes , 2016, Autom..
[31] M Berman,et al. Modeling the insulin-glucose system in man. , 1974, Federation proceedings.
[32] Robert G. Sutherlin,et al. A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.
[33] Thomas Danne,et al. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy , 2012, Pediatric diabetes.
[34] Nejat Olgaç,et al. Bounds of imaginary spectra of LTI systems in the domain of two of the multiple time delays , 2016, Autom..
[35] G. Steil,et al. Impact of Fat, Protein, and Glycemic Index on Postprandial Glucose Control in Type 1 Diabetes: Implications for Intensive Diabetes Management in the Continuous Glucose Monitoring Era , 2015, Diabetes Care.
[36] C. Cobelli,et al. Progress in Development of an Artificial Pancreas , 2009, Journal of diabetes science and technology.
[37] T. Kaczorek. Positive 1D and 2D Systems , 2001 .
[38] Ewa Pańkowska,et al. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes , 2009, Pediatric diabetes.
[39] Garry M. Steil,et al. Identification of Intraday Metabolic Profiles during Closed-Loop Glucose Control in Individuals with Type 1 Diabetes , 2009, Journal of diabetes science and technology.
[40] Josep Vehí,et al. A review of personalized blood glucose prediction strategies for T1DM patients , 2017, International journal for numerical methods in biomedical engineering.
[41] J. Freudenberg,et al. Right half plane poles and zeros and design tradeoffs in feedback systems , 1985 .
[42] Rick H. Middleton,et al. Trade-offs in linear control system design , 1991, Autom..
[43] Jie Chen. Sensitivity Integral Relations and Design Tradeoffs in Linear Multivariable Feedback Systems , 1993, 1993 American Control Conference.
[44] Stephen P. Boyd,et al. Convex Optimization , 2004, Algorithms and Theory of Computation Handbook.
[45] S W Lee,et al. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes. , 2004, Diabetes, nutrition & metabolism.
[46] Graham C. Goodwin,et al. A performance limitation for blood glucose regulation in type 1 diabetes accounting for insulin delivery delays , 2016, 2016 IEEE 55th Conference on Decision and Control (CDC).
[47] B. Wayne Bequette,et al. Challenges and recent progress in the development of a closed-loop artificial pancreas , 2012, Annu. Rev. Control..
[48] Darrell M. Wilson,et al. A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.
[49] J. Leahy,et al. Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .
[50] Graham C. Goodwin,et al. A fundamental control limitation for linear positive systems with application to Type 1 diabetes treatment , 2015, Autom..
[51] W. Tamborlane,et al. The Artificial Pancreas: Are We There Yet? , 2014, Diabetes Care.
[52] Scott A. Kaestner,et al. Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs , 2010, Pharmaceutical Research.